Resources

Human Peripheral Blood-derived Cultured Mast Cells A cellular model to study injection site reactions & severe allergic reactions. In vitro mast cell culture assays are critical to better understand the kinetics and dynamics underlying inflammatory reactions. Genoskin has developed a method to culture Human Peripheral Blood-derived Cultured Mast Cells (PBCMCs) from healthy individuals. We isolate CD34+ progenitors from PBMCs ofRead more

Genoskin launches new skin offering, NativeSkin® access, that increases accessibility to animal testing alternatives NativeSkin, the only ex vivo human skin model sold online, will be available to purchase daily at a key price point, making it easier to order even for larger volume sales Toulouse, France & Salem, MA, USA, September 1, 2020 - Genoskin, a biotechnology company developing ready-to-use human skinRead more

Brand new sustainable and user-friendly packaging! After months of reflection, design trials, and careful sourcing, Genoskin is proud to reveal its brand new packaging. Thanks to Marta Wolska-Brys (Packaging & Beyond, LLC) and her expert support we designed our dream packaging. You will soon get to see it in your labs! It’s awesome! We designed this new packaging with yourRead more

Top differences between human and animal skin Are animal models used in skin research? Animal models have been widely used in skin research. They are often used to study percutaneous absorption, wound healing, skin inflammation and psoriasis. These studies require relevant models in terms of structure and immunology to assess human skin response and to de-risk clinical trials on humans. TheRead more

 The US Environmental Protection Agency (EPA) determined to eliminate animal testing The US Environmental Protection Agency announced yesterday its plan to stop animal use for chemical safety testing. The U.S. EPA rolled out a plan this week to end all animal testing for chemical and pesticide safety in the coming years. To help the transition, the agency will invest in nonanimal alternative methodsRead more

Skin biotech to set up Boston production unit that recycles excess human skin Toulouse, France, August 29, 2017 – Genoskin, a company that provides a cutting-edge alternative to animal testing by keeping donated human skin alive, today announces its expansion into North America. The biotech has established a representative office in Boston and plans to open a local production unitRead more